Shopping Cart

Investor Presentation — Imagion Biosystems MagSense® Technology

Investor Presentation — Imagion Biosystems MagSense® Technology

President and CEO Bob Proulx today addressed investors at the Switzer Small and Microcap Investor Day in Sydney Australia. He discussed recent milestones, including FDA breakthrough Device Designation, and what Imagion Biosystems expects to achieve in 2020.

Download the presentation.

Related Articles

Transforming medical imaging for early disease detection

We’re on a mission to make cancer more detectable.